Subject wise

Ch 1 Antacids 1 → Ch 2 Circulatory shock 1 → Ch 3 Prokinetic drugs 1 → Ch 4 Peptic ulcer disease 1 → Ch 5 Acute inflammation 2 → Ch 6 Pneumothorax 2 → Ch 7 Glomerular filtration 1 → Ch 8 Autonomic ganglia 1 → Ch 9 Diabetes insipidus 4 → Ch 10 Pupillary light reflex 1 → Ch 11 Basal Ganglia 3 → Ch 12 Purine metabolism and Lesch–Nyhan syndrome 2 → Ch 13 Innervation of the hand 2 → Ch 14 Umbilical and abdominal wall abnormalities 1 → Ch 15 Leukocyte extravasation 1 → Ch 16 p53 and DNA damage 1 → Ch 17 Tetracycline mechanism of action 1 → Ch 18 Respiratory changes in pregnancy 3 → Ch 19 Coagulation changes in pregnancy 1 → Ch 20 Acid–base disorders 4 → Ch 21 Obstructive and restrictive lung physiology 4 → Ch 22 Cerebrospinal fluid properties 1 → Ch 23 Body fluid compartments 5 → Ch 24 Internal capsule 2 → Ch 25 Trachoma prevention 1 → Ch 26 Drug-induced congenital abnormalities 2 → Ch 27 Cerebral arterial territories 1 → Ch 28 Inhalational anaesthetics 6 → Ch 29 Organophosphate poisoning 1 → Ch 30 Respiratory carcinogens and epithelial changes 3 → Ch 31 Beta-2 agonists 2 → Ch 32 Cytomegalovirus colitis 1 → Ch 33 Polycythaemia vera 1 → Ch 34 Elastin and supravalvular aortic stenosis 1 → Ch 35 Hepatocellular accumulation 1 → Ch 36 Motilin and fasting motility 1 → Ch 37 Heparin selection and monitoring 3 → Ch 38 Amiodarone and thyroid dysfunction 1 → Ch 39 Monoamine oxidase inhibitor interactions 2 → Ch 40 Gas and fluid flow laws 7 → Ch 41 Multiple myeloma 1 → Ch 42 Arterial pressure transducers 1 → Ch 43 Spinal accessory nerve 2 → Ch 44 Local anaesthetic systemic toxicity 1 → Ch 45 Somite and skeletal muscle development 1 → Ch 46 Scapular stabilisation 2 → Ch 47 Tocolytic drugs 1 → Ch 48 Splenic trauma 1 → Ch 49 Aortocaval compression in pregnancy 1 → Ch 50 Bronchial anatomy and aspiration 1 → Ch 51 Antiemetics and prokinetic drugs 4 → Ch 52 Starling forces and filtration 1 → Ch 53 Neonatal ventilation 1 → Ch 54 Ejection fraction and ventricular volumes 1 → Ch 55 Loading dose and volume of distribution 2 → Ch 56 Disinfection and sterilisation 5 → Ch 57 Action potentials and refractory periods 1 → Ch 58 Systemic thromboembolism 2 → Ch 59 Apoptosis 2 → Ch 60 Inguinal canal anatomy 1 → Ch 61 Temperature monitoring 1 → Ch 62 Cardiac drug mechanisms 2 → Ch 63 Surface anatomy of the heart 2 → Ch 64 Diuretic mechanisms and adverse effects 5 → Ch 65 Opioid pharmacology 2 → Ch 66 Intravenous anaesthetics 1 → Ch 67 Helminthic infections 2 → Ch 68 Chronic myeloid leukaemia 1 → Ch 69 Vitamin K and anticonvulsants 1 → Ch 70 Middle ear effusion and tympanometry 1 → Ch 71 Contact activation of coagulation 1 → Ch 72 Bacterial meningitis 1 → Ch 73 Sickle cell disease 1 → Ch 74 Community-acquired pneumonia 1 → Ch 75 Cardiac output during exercise 1 → Ch 76 Glucocorticoid adverse effects 1 → Ch 77 Antimuscarinic bronchodilators 2 → Ch 78 Deep fibular nerve 1 → Ch 79 Capnography 1 → Ch 80 Great saphenous vein 1 → Ch 81 Postmortem clotting 1 → Ch 82 Pudendal nerve 4 → Ch 83 Leukotriene receptor antagonists 1 → Ch 84 Branched-chain amino acid metabolism 1 → Ch 85 Vulval lymphatic drainage 1 → Ch 86 Hydrocele 1 → Ch 87 Riboflavin deficiency 1 → Ch 88 Biotin-dependent carboxylation 1 → Ch 89 Aphasia and language localisation 3 → Ch 90 Hyperaemia 1 → Ch 91 Neuraxial anatomy 2 → Ch 92 Knee flexion 1 → Ch 93 Neurogenic bladder 1 → Ch 94 Urea cycle and hepatic encephalopathy 1 → Ch 95 Cholesterol biosynthesis 1 → Ch 96 Botulinum toxin 1 → Ch 97 Myasthenia gravis 3 → Ch 98 Pericardial innervation 1 → Ch 99 Turner syndrome 1 → Ch 100 Facial nerve lesions 7 → Ch 101 Uterine tube histology 1 → Ch 102 Aspirin pharmacology 2 → Ch 103 Perioperative anticoagulant interruption 1 → Ch 104 Coronary arterial territories 1 → Ch 105 Innate antiviral immunity 1 → Ch 106 Neuromuscular blocking drugs 4 → Ch 107 Intraoperative blood pressure control 1 → Ch 108 Iron deficiency anaemia 1 → Ch 109 Anticonvulsants and enzyme induction 1 → Ch 110 Spinal pain transmission 1 → Ch 111 Intra-articular treatment of knee pain 1 → Ch 112 Subarachnoid haemorrhage 1 → Ch 113 Anaphylaxis 1 → Ch 114 Codominance 1 → Ch 115 Dopamine and prolactin 1 → Ch 116 Physiological effects of stress 1 → Ch 117 Non-thyroidal illness syndrome 1 → Ch 118 Antihypertensive withdrawal 1 → Ch 119 Phaeochromocytoma pharmacotherapy 1 → Ch 120 Cirrhotic ascites 1 → Ch 121 Upper motor neuron lesions 1 → Ch 122 Mallory–Weiss tear 1 → Ch 123 Respiratory quotient 1 → Ch 124 Local anaesthetic dosing and toxicity 1 → Ch 125 Varicocele 1 → Ch 126 ASA physical status classification 1 → Ch 127 Bispectral index monitoring 1 → Ch 128 Aspiration risk and patient positioning 1 → Ch 129 Oesophageal constrictions and nasogastric intubation 1 → Ch 130 Pulse oximetry and Beer–Lambert law 2 → Ch 131 Marfan syndrome and fibrillin 2 → Ch 132 Proteus urinary tract infection 1 → Ch 133 Branched-chain amino acid metabolism and maple syrup urine disease 3 → Ch 134 Acute transfusion reactions 1 → Ch 135 Perioperative anaphylaxis 1 → Ch 136 Monoamine oxidase inhibitors and sympathomimetic interactions 1 → Ch 137 Emergency vascular access 1 → Ch 138 NSAIDs and gastrointestinal toxicity 1 → Ch 139 Lambert–Eaton myasthenic syndrome 1 → Ch 140 Community-acquired pneumonia treatment 1 → Ch 141 Gag reflex pathways 1 → Ch 142 Scapular muscle attachments 1 → Ch 143 Reversible and irreversible cell injury 1 → Ch 144 Common fibular nerve injury and foot drop 2 → Ch 145 Fluoroquinolone mechanism and adverse effects 2 → Ch 146 Proton pump inhibitors 1 → Ch 147 Deep cervical fascia and neck spaces 1 → Ch 148 ECG intervals and heart rate 1 → Ch 149 Ileal bile acid absorption 1 → Ch 150 Intrinsic factor and vitamin B12 absorption 1 → Ch 151 Gastric lymphatic drainage 1 → Ch 152 Fetal bradycardia and hypoxia 1 → Ch 153 Pterion and middle meningeal artery injury 1 → Ch 154 Intracranial pressure management 1 → Ch 155 Internal capsule lesion localisation 1 → Ch 156 Salivatory nuclei and parasympathetic innervation 1 → Ch 157 Ketamine and dissociative anaesthesia 1 → Ch 158 Anaerobic glycolysis and lactate formation 1 → Ch 159 Axillary brachial plexus block 2 → Ch 160 Phenylalanine metabolism and phenylketonuria 1 → Ch 161 Polycystic kidney disease inheritance 1 → Ch 162 Klinefelter syndrome and nondisjunction 1 → Ch 163 p53 and DNA damage response 1 → Ch 164 Pyruvate carboxylase and biotin 2 → Ch 165 Gaucher disease and glucocerebrosidase 1 → Ch 166 Lipoprotein lipase deficiency and hypertriglyceridaemia 1 → Ch 167 Cerebral infarction and liquefactive necrosis 2 → Ch 168 Sulfonylurea-induced hypoglycaemia 1 → Ch 169 Perioperative dabigatran interruption 432 → Ch 170 Renal arteriolar resistance and glomerular filtration 2 → Ch 171 Rocuronium ED95 and neuromuscular blockade 2 → Ch 172 Drug-induced hyperkalaemia 1 → Ch 173 Local anaesthetic mechanism of action 2 → Ch 174 Restrictive lung disease and lung volumes 1 → Ch 175 Obstructive spirometry in asthma 1 → Ch 176 Oxygen cylinder duration 1 → Ch 177 Boyle’s law and gas volume 1 → Ch 178 Leukocyte adhesion and transmigration 2 → Ch 179 Hand-foot-and-mouth disease and enteroviruses 1 → Ch 180 Flumazenil and benzodiazepine reversal 1 → Ch 181 Immunoglobulins and complement activation 1 → Ch 182 Ventricular septal defect and pansystolic murmur 1 → Ch 183 Transfusion-associated hypocalcaemia 1 → Ch 184 Organophosphate poisoning and antidotes 1 → Ch 185 Spinal needle paraesthesia and nerve injury prevention 1 → Ch 186 Coagulation pathways and screening tests 1 → Ch 187 Vitamin K-dependent coagulation factors 1 → Ch 188 Thrombolytic-associated bleeding reversal 2 → Ch 189 Anticoagulation in pregnancy 1 → Ch 190 Drug protein binding in liver disease 1 → Ch 191 Dietary management of metabolic risk 1 → Ch 192 Intraoperative hypertension management 2 → Ch 193 Amiodarone-induced thyroid dysfunction 1 → Ch 194 Complete atrioventricular block 1 → Ch 195 Hepatocyte apoptosis and Councilman bodies 1 → Ch 196 Tumour grading and differentiation 1 → Ch 197 Axillary nerve injury 1 → Ch 198 Malignant hyperthermia 3 → Ch 199 Antipsychotic-induced acute dystonia 1 → Ch 200 Measures of central tendency 1 → Ch 201 Paediatric foreign body aspiration 1 → Ch 202 Pyruvate dehydrogenase cofactors 1 → Ch 203 Potassium disturbances and cardiac excitability 1 → Ch 204 Plague transmission and vectors 1 → Ch 205 Chronic lymphocytic leukaemia 1 → Ch 206 Blood product selection and uraemic bleeding 1 → Ch 207 Nephrotic syndrome and podocyte injury 1 → Ch 208 Clostridium perfringens infection treatment 1 → Ch 209 Pernicious anaemia and intrinsic factor deficiency 1 → Ch 210 Varicella-zoster infection 1 → Ch 211 Posterior cranial fossa contents 1 → Ch 212 Invasive arterial blood pressure monitoring 1 → Ch 213 Oscillometric blood pressure measurement 1 → Ch 214 Antianginal drug therapy 2 → Ch 215 Chronic passive hepatic congestion 1 → Ch 216 Mean arterial pressure and systemic vascular resistance 2 → Ch 217 Exercise-associated heat cramps 1 → Ch 218 Retinoid teratogenicity 2 → Ch 219 L5 myotome and great toe dorsiflexion 1 → Ch 220 Peripheral nerve injury around the ankle 1 → Ch 221 Down syndrome and gene dosage 3 → Ch 222 Turner mosaicism and Barr bodies 1 → Ch 223 Primary aldosteronism 1 → Ch 224 Electrosurgical return electrode safety 3 → Ch 225 Laryngeal innervation 3 → Ch 226 Subclavian vein relations 1 → Ch 227 Hyperkalaemia and ECG changes 1 → Ch 228 PEEP effects and ventilator-associated barotrauma 1 → Ch 229 Hypothermia-associated coagulopathy 1 → Ch 230 Environmental cleaning and blood-borne infection control 2 → Ch 231 Perioperative supraventricular tachycardia management 1 → Ch 232 SIADH and hypotonic hyponatraemia 1 → Ch 233 Vomiting and hypochloraemic metabolic alkalosis 1 → Ch 234 Spinal block level for testicular surgery 1 → Ch 235 Imaging guidance for spinal anaesthesia 1 → Ch 236 Intraoperative hypotension management 1 → Ch 237 Patient autonomy and refusal of treatment 1 → Ch 238 Beneficence and non-maleficence 1 → Ch 239 Visual field defects and optic pathway lesions 2 → Ch 240 Cerebellar motor coordination 1 → Ch 241 Vincristine-induced peripheral neuropathy 1 → Ch 242 p53 and MDM2 regulation 1 → Ch 243 Nerve fibre types and pain transmission 3 → Ch 244 Oxyhaemoglobin dissociation curve 1 → Ch 245 Lipoprotein(a) and fibrinolysis 1 → Ch 246 Serratus anterior and scapular stabilisation 1 → Ch 247 Proximal tubular bicarbonate reabsorption 1 → Ch 248 Hypothyroidism and levothyroxine 1 → Ch 249 Parkinson disease and substantia nigra degeneration 2 → Ch 250 Gq–phospholipase C signalling 1 → Ch 251 Sickle cell disease and beta-globin mutation 1 → Ch 252 Sickle cell vaso-occlusive crisis 1 → Ch 253 Inflammatory cytokines and fever 1 → Ch 254 Splenic injury and left lower rib fractures 1 → Ch 255 Astrocytic tumours and GFAP 2 → Ch 256 Supravalvular aortic stenosis and elastin 1 → Ch 257 Transient ischaemic attack 1 → Ch 258 Body fluid compartments and sweat replacement 1 → Ch 259 Chloride-responsive alkalosis and paradoxical aciduria 2 → Ch 260 Type II collagen and cartilage 1 → Ch 261 Congenital erythropoietic porphyria 1 → Ch 262 Metoclopramide and diabetic gastroparesis 2 → Ch 263 Naloxone duration and recurrent opioid toxicity 1 → Ch 264 Phaeochromocytoma and alpha blockade 1 → Ch 265 Lipid assessment and cardiovascular risk 1 → Ch 266 Basal ganglia anatomy 2 → Ch 267 Peritubular capillary reabsorption 1 → Ch 268 LCAT deficiency and cholesterol esterification 1 → Ch 269 Acute back symptoms and assessment 1 → Ch 270 Tracheal tube placement confirmation 1 → Ch 271 Venturi masks and controlled oxygen delivery 2 → Ch 272 Huntington disease and caudate degeneration 1 → Ch 273 Apoptosis and BCL2 family proteins 3 → Ch 274 Giant cell arteritis 1 → Ch 275 Inhalational anaesthetic solubility and kinetics 1 → Ch 276 Paediatric airway dimensions 2 → Ch 277 Thyroid and adrenal disorders 6 → Ch 278 Coagulation pathways 2 → Ch 279 Liddle syndrome 1 → Ch 280 Innervation of the lower limb 3 → Ch 281 Glycogen storage disorders 1 → Ch 282 Cancer epidemiology 1 → Ch 283 Essential tremor treatment 1 → Ch 284 Amino acid metabolism 1 → Ch 285 Ventricular tachycardia treatment 2 → Ch 286 Anxiolytics and antidepressants 3 → Ch 287 Sympathomimetic toxicity 1 → Ch 288 Urea cycle disorders 1 → Ch 289 Raised intracranial pressure 1 → Ch 290 Local blood flow regulation 1 → Ch 291 Anaesthesia machine safety 1 → Ch 292 Thyroid storm treatment 1 → Ch 293 Recurrent laryngeal nerve 1 → Ch 294 Alpha-adrenergic antagonists 1 → Ch 295 Pulmonary thromboembolism 2 → Ch 296 Intestinal lymphoid tissue 1 → Ch 297 Perioperative medication management 1 → Ch 298 Coronary arterial supply 1 → Ch 299 Femoral hernia 1 → Ch 300 Regional pulmonary blood flow 2 → Ch 301 Autonomic control of sexual function 2 → Ch 302 Brachial plexus injuries 1 → Ch 303 Axillary nerve 1 → Ch 304 Hirschsprung disease 1 → Ch 305 Cardiac action potentials 1 → Ch 306 Pericardial effusion 1 → Ch 307 Valvular heart disease 3 → Ch 308 Membrane action potentials 1 → Ch 309 Lung volumes and body position 1 → Ch 310 Heparin and reversal 2 → Ch 311 Cirrhosis complication management 2 → Ch 312 Airway management 1 → Ch 313 Spinal cord tract lesions 2 → Ch 314 Urethral caruncle 1 → Ch 315 Guillain–Barré syndrome 1 → Ch 316 Caudal epidural anatomy 1 → Ch 317 Pulmonary surfactant 1 → Ch 318 Adaptation to altitude 2 → Ch 319 Pancreatic ducts 1 → Ch 320 Squamous cell carcinoma 1 → Ch 321 Wound healing and scars 1 → Ch 322 Acute heart failure 1 → Ch 323 Urinary system development 2 → Ch 324 Renin–angiotensin–aldosterone system 1 → Ch 325 Acute tubular injury 1 → Ch 326 Autosomal dominant inheritance 2 → Ch 327 Mitochondrial inheritance 1 → Ch 328 Radiation injury 1 → Ch 329 Cell injury and death 7 → Ch 330 Type IV hypersensitivity 1 → Ch 331 Antigen presentation 1 → Ch 332 G6PD deficiency 1 → Ch 333 Pernicious anaemia 1 → Ch 334 Alcohol-related liver disease 2 → Ch 335 Salicylate toxicity 1 → Ch 336 Proteus infection 1 → Ch 337 Malaria 1 → Ch 338 Syphilis 1 → Ch 339 Polymerase chain reaction 1 → Ch 340 Herpesvirus latency 1 → Ch 341 Diphtheria toxin 1 → Ch 342 Chemical carcinogenesis 1 → Ch 343 Hypoxic pulmonary vasoconstriction 1 → Ch 344 Chest trauma 1 → Ch 345 Central control of breathing 1 → Ch 346 Analgesics and gastric safety 1 → Ch 347 Gallbladder and biliary disease 2 → Ch 348 Gag reflex 1 → Ch 349 Trigeminal nerve 1 → Ch 350 Jugular foramen 1 → Ch 351 Hippocampus and memory 1 → Ch 352 Hypothalamic control of appetite 1 → Ch 353 Subarachnoid haemorrhage treatment 1 → Ch 354 Cerebellar function 1 → Ch 355 Parkinson disease pharmacology 1 → Ch 356 Glial tumours 1 → Ch 357 Ribonucleotide reductase 2 → Ch 358 Vitamin E deficiency 1 → Ch 359 Vinca alkaloids 1 → Ch 360 Human papillomavirus 2 → Ch 361 Intestinal lipid absorption 1 → Ch 362 Clostridial myonecrosis 1 → Ch 363 Ocular development 1 → Ch 364 Quantal dose–response relationships 1 → Ch 365 Stratified sampling 1 → Ch 366 Patient confidentiality 2 → Ch 367 Knee bursae 1 → Ch 368 Crohn disease 1 → Ch 369 Platelet activation 1 → Ch 370 Disease-modifying antirheumatic drugs 1 → Ch 371 Ectopic pregnancy 1 → Ch 372 Vitamin D assessment 1 → Ch 373 Prenatal screening 1 → Ch 374 Benzodiazepine structure 1 → Ch 375 Antidiarrhoeal drugs 1 → Ch 376 Citrate anticoagulation 1 → Ch 377 Potassium-sparing diuretics 1 → Ch 378 Aerobic glycolysis and pyruvate formation 1 → Ch 379 McArdle disease and muscle glycogen phosphorylase 1 → Ch 380 Essential and non-essential amino acids 1 → Ch 381 Warfarin and antibiotic interactions 1 → Ch 382 Alpha-1 blockers and first-dose hypotension 1 → Ch 383 Leflunomide toxicity and accelerated elimination 1 → Ch 384 Acute asthma exacerbation treatment 1 → Ch 385 Perioperative antihypertensive and diabetes medication management 1 → Ch 386 MRSA skin infection treatment 1 → Ch 387 Antibiotic selection in penicillin allergy 2 → Ch 388 ACE inhibitor cough and bradykinin 1 → Ch 389 Neural tube closure defects 1 → Ch 390 Bile salts and fat emulsification 1 → Ch 391 Infrared temperature measurement 1 → Ch 392 Oxygen supply pressure and fail-safe mechanisms 2 → Ch 393 Mechanisms of viral cell injury 1 → Ch 394 Opsonisation and phagocytosis 1 → Ch 395 Immunoglobulin structure and function 1 → Ch 396 Clostridial structure and sporulation 1 → Ch 397 Ureteric referred pain and genitofemoral nerve 1 → Ch 398 Epstein–Barr virus and Burkitt lymphoma 1 → Ch 399 Onchocerciasis and ivermectin reactions 1 → Ch 400 Spinal needle anatomical layers 1 → Ch 401 Patau and Edwards syndromes 1 → Ch 402 Hydrocephalus imaging 1 → Ch 403 Follicular thyroid carcinoma and invasion 1 → Ch 404 Muscle glycogen and endurance exercise 1 → Ch 405 Dystrophic and metastatic calcification 1 → Ch 406 BCG and cell-mediated immunity 1 → Ch 407 Natural killer and cytotoxic T-cell activity 1 → Ch 408 Mid-luteal progesterone and ovulation 1 → Ch 409 ECG axis deviation 1 → Ch 410 Cell-wall-deficient bacteria 1 → Ch 411 Cutaneous porphyrias and haem synthesis 1 → Ch 412 Thiopental redistribution 1 → Ch 413 Histamine synthesis from histidine 1 → Ch 414 Cortisol synthesis inhibitors in Cushing syndrome 1 → Ch 415 Essential fatty acids 1 → Ch 416 Mast-cell stabilisers and asthma prophylaxis 1 → Ch 417 Von Gierke disease and glucose-6-phosphatase 1 → Ch 418 Central and peripheral facial weakness localisation 1 → Ch 419 Antithyroid treatment in pregnancy 1 → Ch 420 Starling forces and capillary fluid exchange 1 → Ch 421 Upper-limb dermatomes and lower brachial plexus 1 → Ch 422 Gastroduodenal artery and duodenal relations 1 → Ch 423 Renal tubular dilution of urine 1 → Ch 424 Fick principle and cardiac output 1 → Ch 425 Charles’ law and gas temperature 1 → Ch 426 Endobronchial intubation 1 → Ch 427 Anthracosis and carbon pigment 1 → Ch 428 Ventricular escape rhythm in complete heart block 1 → Ch 429 Fibrinoid vascular injury and testicular infarction 1 → Ch 430 Gallbladder epithelium 1 → Ch 431 Paracetamol hepatotoxicity 1 → Ch 432 Neonatal lupus and congenital heart block 1 → Ch 433 Pudendal nerve roots 1 → Ch 434 Inhalational anaesthetic blood–gas partition coefficients 1 → Ch 435 Prepatellar bursitis 1 → Ch 436 Succinylcholine-associated hyperkalaemia after burns 1 → Ch 437 Rocuronium for rapid sequence intubation 1 → Ch 438 Factor V Leiden and venous thrombosis 1 → Ch 439 Fluid challenges in cardiogenic shock 1 → Ch 440 Sinoatrial node action potentials 1 → Ch 441 Obsessive-compulsive disorder pharmacotherapy 2 → Ch 442 MSSA osteomyelitis treatment 1 → Ch 443 ADHD pharmacotherapy 1 → Ch 444 Surgical antibiotic prophylaxis timing 1 → Ch 445 Cefazolin surgical prophylaxis 1 → Ch 446 Transplant graft types 1 → Ch 447 Crystalloid osmolarity and osmolality 1 → Ch 448 Spinal sympathetic blockade and hypotension 2 → Ch 449 Autonomic control of erection and ejaculation 1 → Ch 450 Nitrous oxide potency and analgesia 1 → Ch 451 Orotic aciduria and UMP synthase deficiency 1 → Ch 452 Orifice flow and pressure gradients 1 → Ch 453 Symptomatic varicose veins management 1 → Ch 454 Drug-susceptible tuberculosis intensive-phase treatment 1 → Ch 455 Metronidazole and anaerobic oral infection 1 → Ch 456 Stratified random sampling 1 → Ch 457 Ethylene oxide sterilisation cycles 1 → Ch 458 Aspiration prophylaxis and sodium citrate 1 → Ch 459 Vaccine-induced immune thrombotic thrombocytopenia 1 → Ch 460 Platelet activation and shape change 1 → Ch 461 Airway management with cervical spine injury 1 → Ch 462 Primary prophylaxis of variceal bleeding 1 → Ch 463 Opioid-induced respiratory depression 1 → Ch 464 Assessment of vitamin D status 1 → Ch 465 Vapour pressure and temperature 1 → Ch 466 Gas density and molecular weight 1 → Ch 467 Medium-chain triglycerides in fat malabsorption 1 → Ch 468 Hyperglycaemia and diabetic kidney injury 1 → Ch 469 Amphetamine withdrawal management 1 → Ch 470 Thiamine deficiency and Wernicke encephalopathy 1 → Ch 471 Oogenesis and the ovulated oocyte 1 → Ch 472 Alkaptonuria and homogentisate metabolism 1 → Ch 473 MHC class I antigen presentation 1 → Ch 474 Paracetamol overdose and N-acetylcysteine 1 → Ch 475 Heparin reversal with protamine 1 → Ch 476 Airway anatomy and foreign body distribution 1 → Ch 477 Middle cerebral artery stroke localisation 1 → Ch 478 Medullary thyroid carcinoma markers 1 → Ch 479 Decompression sickness and nitrogen bubbles 1 → Ch 480 Heart failure with subclinical hypothyroidism 1 →

No topics match.